Abstract:Dissecting large bulk RNA-seq data into cell proportions and cell type specific expression profiles could significantly enhance our understanding of disease mechanisms at cell level and facilitate the identification of novel drug targets and development of efficient intervention strategies. In this study, we presented a scRNA-seq marker (gene) informed cell deconvolution and expression inference (CausalCellInfer) framework. CausalCellInfer employed causal inference principles to automatically identify a small set of critical marker genes from the reference scRNA-seq dataset. It then integrates deep neural networks with regularized matrix completion algorithms to deconvolute cell proportions and estimate cell type specific (CTS) expression profiles. Most importantly, we pioneered the application of the proposed framework to imputed expression data from large-scale genome-wide association studies (GWAS). We verified the efficacy of our proposed method by comparing it against existing state-of-the-art cell deconvolution methods, including CIBERSORTx, DWLS, Scaden, and MuSic across various real and pseudo-bulk samples. Furthermore, we proposed the use of a wide range of enrichment analyses to demonstrate the reliability of CausalCellInfer in estimating CTS profiles. Our proposed framework consistently outperformed existing methods with significantly higher concordance correlation coefficient (CCC), lower mean absolute error (MAE) and root mean square error (RMSE) across all testing real and pseudo bulk samples. Importantly, it also demonstrated superior computational efficiency compared to all benchmarked methods except MuSic. We also applied our trained models to deconvolute 4 tissue-specific expression cell proportions and estimate the corresponding CTS expression profiles, leveraging UK Biobank data (UKBB). We conducted a series of cellular-level analyses, including cell proportion association analysis, causal gene detection, transcriptome wide association analysis (TWAS), for 24 phenotypes in UKBB based on estimated cell composition and CTS expression profiles. Of note, the estimated proportions of various cell types were indicative of disease onset. For example, T2DM patients demonstrated a significant decrease in the proportions of alpha and beta cells in comparison to controls. We also tested their associations. Our method exhibited satisfactory positive predictive values (PPV) in uncovering differentially expressed (DE) genes for the majority of cell types. Encouragingly, most identified CTS causally relevant genes were found to be significantly enriched in target diseases or related pathophysiology. In conclusion, we presented a novel framework for inferring cell-type proportions and CTS expression, with novel applications to GWAS-imputed expression data from large-scale biobank program. Our work also shed light on how differential cell-type proportion and CTS expression may be associated with susceptibility to different diseases and their prognoses, bridging scRNA-seq and clinical phenotypes in large-scale biobank studies.

An AutoEncoder-Based Matrix Factorization Approach to Estimating Cell Proportion from Bulk Tumor RNA-seq Data.

DeepDecon Accurately Estimates Cancer Cell Fractions in Bulk RNA-seq Data

Calculation of Immune Cell Proportion from Batch Tumor Gene Expression Profile Based on Support Vector Regression

Adaptive Regularized Tri-Factor Non-Negative Matrix Factorization for Cell Type Deconvolution

Cell Type-Specific Deconvolution Of Heterogeneous Tumor Samples With Immune Infiltration Using Expression Data

Deconvolution Of Heterogeneous Tumor Samples Using Partial Reference Signals

Abstract 2439: A Semi-Supervised Deconvolution Method for Quantifying the Composition and Activity of Tumor-Infiltrating Cell Types

Approximate Estimation of Cell-Type Resolution Transcriptome in Bulk Tissue Through Matrix Completion.

Cancer-associated fibroblast-derived gene signature discriminates distinct prognoses by integrated single-cell and bulk RNA-seq analyses in breast cancer

Robust and accurate estimation of cellular fraction from tissue omics data via ensemble deconvolution

ICTD: Inference of cell types and deconvolution -- a next-generation deconvolution method for accurate assess cell population and activities in tumor microenvironment.

DCAE: Selecting Discriminative Genes on Single-cell RNA-seq Data for Cell-type Quantification

Simultaneous enumeration of cancer and immune cell types from bulk tumor gene expression data

ARIC: accurate and robust inference of cell type proportions from bulk gene expression or DNA methylation data

Highly Accurate Estimation of Cell Type Abundance in Bulk Tissues Based on Single‐Cell Reference and Domain Adaptive Matching

Estimating cell compositions and cell-type-specific expressions from GWAS data using invariant causal prediction, deep learning and regularized matrix completion

A Multi-Scale Conditional Deep Model for Tumor Cell Ratio Counting

Post‐modified Non‐negative Matrix Factorization for Deconvoluting the Gene Expression Profiles of Specific Cell Types from Heterogeneous Clinical Samples Based on RNA‐sequencing Data

Construction of a Matrix Cancer-Associated Fibroblast Signature Gene-Based Risk Prognostic Signature for Directing Immunotherapy in Patients with Breast Cancer Using Single-Cell Analysis and Machine Learning

Estimation of cell lineages in tumors from spatial transcriptomics data

Discovery and Construction of Prognostic Model for Clear Cell Renal Cell Carcinoma Based on Single-Cell and Bulk Transcriptome Analysis